Insider Selling: Intuitive Surgical (NASDAQ:ISRG) Director Sells $435,000.00 in Stock

Intuitive Surgical, Inc. (NASDAQ:ISRG) Director Craig Barratt sold 750 shares of the firm’s stock in a transaction dated Wednesday, November 12th. The shares were sold at an average price of $580.00, for a total transaction of $435,000.00. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink.

Intuitive Surgical Price Performance

Shares of ISRG stock traded down $4.73 during trading hours on Thursday, reaching $567.72. 1,207,919 shares of the company were exchanged, compared to its average volume of 2,119,727. Intuitive Surgical, Inc. has a fifty-two week low of $425.00 and a fifty-two week high of $616.00. The stock’s fifty day moving average is $478.64 and its two-hundred day moving average is $502.49. The company has a market cap of $203.51 billion, a price-to-earnings ratio of 75.07, a P/E/G ratio of 4.94 and a beta of 1.62.

Intuitive Surgical (NASDAQ:ISRG) last posted its quarterly earnings data on Tuesday, October 21st. The medical equipment provider reported $2.40 earnings per share for the quarter, topping the consensus estimate of $1.99 by $0.41. The firm had revenue of $2.51 billion during the quarter, compared to analysts’ expectations of $2.41 billion. Intuitive Surgical had a net margin of 28.58% and a return on equity of 15.08%. Intuitive Surgical’s revenue was up 22.9% on a year-over-year basis. During the same quarter in the previous year, the company posted $1.84 EPS. On average, research analysts anticipate that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current year.

Hedge Funds Weigh In On Intuitive Surgical

Institutional investors and hedge funds have recently made changes to their positions in the company. Vanguard Group Inc. grew its stake in Intuitive Surgical by 0.8% in the third quarter. Vanguard Group Inc. now owns 33,599,661 shares of the medical equipment provider’s stock valued at $15,026,776,000 after acquiring an additional 263,828 shares during the period. State Street Corp raised its position in shares of Intuitive Surgical by 1.2% during the second quarter. State Street Corp now owns 15,552,203 shares of the medical equipment provider’s stock worth $8,451,223,000 after purchasing an additional 182,871 shares during the period. Geode Capital Management LLC lifted its holdings in shares of Intuitive Surgical by 1.4% during the 2nd quarter. Geode Capital Management LLC now owns 8,188,685 shares of the medical equipment provider’s stock valued at $4,429,590,000 after purchasing an additional 109,904 shares in the last quarter. Capital World Investors grew its position in shares of Intuitive Surgical by 1.5% in the 3rd quarter. Capital World Investors now owns 7,728,492 shares of the medical equipment provider’s stock valued at $3,456,223,000 after purchasing an additional 116,034 shares during the period. Finally, Norges Bank acquired a new position in shares of Intuitive Surgical in the 2nd quarter valued at approximately $2,569,260,000. Institutional investors and hedge funds own 83.64% of the company’s stock.

Analyst Upgrades and Downgrades

Several equities analysts recently issued reports on the company. Truist Financial set a $620.00 price target on Intuitive Surgical and gave the company a “buy” rating in a report on Wednesday, October 22nd. Rothschild & Co Redburn upped their target price on shares of Intuitive Surgical from $610.00 to $615.00 and gave the company a “buy” rating in a research report on Thursday, October 23rd. Hsbc Global Res raised shares of Intuitive Surgical to a “strong-buy” rating in a research note on Thursday, October 23rd. Evercore ISI boosted their price target on shares of Intuitive Surgical from $450.00 to $540.00 in a research note on Wednesday, October 22nd. Finally, Royal Bank Of Canada set a $625.00 price objective on shares of Intuitive Surgical and gave the company an “outperform” rating in a research note on Wednesday, October 22nd. Two analysts have rated the stock with a Strong Buy rating, nineteen have given a Buy rating, seven have given a Hold rating and one has assigned a Sell rating to the company’s stock. According to data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average target price of $608.92.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.